Big Pharma’s Government Revolving Door: ‘Who Do They Really Work For?’
Deep Ties
A KHN data analysis finds the door of opportunities connecting Capitol Hill, the federal government, and the drug industry likely spins in Big Pharma’s favor. Exhibit A: Alex Azar.
